These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19920277)

  • 1. Similarities and differences between REPEAT and EPIC3.
    Poynard T; Shiff E
    Ann Intern Med; 2009 Nov; 151(10):754; author reply 754-5. PubMed ID: 19920277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Has hepatitis C become curable by a new pegylated interferon?].
    Trépo C; Merle P
    Presse Med; 2001 May; 30(18):905-8. PubMed ID: 11413851
    [No Abstract]   [Full Text] [Related]  

  • 3. Response-guided therapy: optimizing treatment now and in the future.
    Marcellin P; Rizzetto M
    Antivir Ther; 2008; 13 Suppl 1():1-2. PubMed ID: 18432156
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful therapy with pegylated interferon alfa-2a. Hepatitis C patients remain virus-free].
    MMW Fortschr Med; 2003 Sep; 145(35-36):56. PubMed ID: 14584218
    [No Abstract]   [Full Text] [Related]  

  • 5. Why do we need another interferon?
    Pockros PJ
    Gastroenterology; 2010 Oct; 139(4):1084-6. PubMed ID: 20800652
    [No Abstract]   [Full Text] [Related]  

  • 6. Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction.
    Keeffe EB
    Semin Liver Dis; 2003; 23 Suppl 1():1-2. PubMed ID: 12934161
    [No Abstract]   [Full Text] [Related]  

  • 7. ADVANCE study begins enrollment.
    AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463
    [No Abstract]   [Full Text] [Related]  

  • 8. Compare trial: updated data.
    Silva MO
    J Hepatol; 2008 Aug; 49(2):288-9. PubMed ID: 18571269
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C virus distribution and clearance following interferon-monotherapy among thalassaemia major and intermedia patients.
    Ricchi P; Lanza AG; Ammirabile M; Costantini S; Cinque P; Spasiano A; Di Matola T; Di Costanzo GG; Pagano L; Prossomariti L
    Br J Haematol; 2011 Nov; 155(4):524-7. PubMed ID: 21564076
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pegylated interferon: new progress in treatment for chronic hepatitis C].
    Boyer N; Marcellin P
    Gastroenterol Clin Biol; 2000; 24(8-9):767-9. PubMed ID: 11011255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic hepatitis C. Better treatment outcome with pegylated interferon].
    MMW Fortschr Med; 2001 Mar; 143(13):51. PubMed ID: 11332022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peg-interferon or pegylated interferon].
    Taeron C
    Rev Infirm; 2003 Jan; (87):51-3. PubMed ID: 12677910
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic hepatitis C in hemodialysis patients.
    Casanovas T
    Hepatology; 2009 Jun; 49(6):2126; author reply 2126. PubMed ID: 19475688
    [No Abstract]   [Full Text] [Related]  

  • 14. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: some concerns.
    Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
    Hepatology; 2009 Jun; 49(6):2125; author reply 2125-6. PubMed ID: 19479790
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
    Zeuzem S
    J Hepatol; 2004 Sep; 41(3):488-90. PubMed ID: 15336454
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C in children: is it necessary and, if so, in whom?
    Alisi A; Comparcola D; Nobili V
    J Hepatol; 2010 Apr; 52(4):472-4. PubMed ID: 20185196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Consensus and peg-interferon in chronic hepatitis C. Therapy for refractory cases?].
    Kaiser S
    MMW Fortschr Med; 2001 Apr; 143(16):36-7. PubMed ID: 11367991
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy.
    Jacobson IM
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):921-30. PubMed ID: 19362605
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible herbal treatment for C4HCV patients who are not suitable for interferon based treatment.
    Canepa J
    Saudi Med J; 2004 Nov; 25(11):1778; author reply 1778. PubMed ID: 15573236
    [No Abstract]   [Full Text] [Related]  

  • 20. Conquering hepatitis C, step by step.
    Schafer DF; Sorrell MF
    N Engl J Med; 2000 Dec; 343(23):1723-4. PubMed ID: 11106723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.